Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bellus Health Inc (BLU)

Bellus Health Inc (BLU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,869,209
  • Shares Outstanding, K 126,812
  • Annual Sales, $ 20 K
  • Annual Income, $ -76,080 K
  • 60-Month Beta 0.19
  • Price/Sales 116,825.55
  • Price/Cash Flow N/A
  • Price/Book 5.06
Trade BLU with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.72
  • Most Recent Earnings $-0.20 on 05/12/23
  • Next Earnings Date 08/09/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.24
  • Number of Estimates 1
  • High Estimate -0.24
  • Low Estimate -0.24
  • Prior Year -0.18
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.39 +2.43%
on 06/15/23
14.76 -0.14%
on 06/26/23
+0.18 (+1.24%)
since 05/26/23
3-Month
6.38 +131.03%
on 04/05/23
14.76 -0.14%
on 06/26/23
+7.60 (+106.44%)
since 03/28/23
52-Week
6.38 +131.03%
on 04/05/23
14.76 -0.14%
on 06/26/23
+5.36 (+57.14%)
since 06/28/22

Most Recent Stories

More News
Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health

/CNW/ - GSK plc (LSE: GSK) (NYSE: GSK) and BELLUS Health Inc. (TSX: BLU) NASDAQ: BLU) today announced GSK has completed the acquisition of BELLUS, a...

BLU : 14.74 (unch)
GSK.LN : 1,595.000 (-0.84%)
GSK : 40.31 (-0.59%)
BLU.TO : 19.48 (-0.10%)
BELLUS Health Announces Meeting Updates

BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“ BELLUS Health ” or the “ Company ”), a clinical-stage biopharmaceutical company working to better the lives of patients suffering from persistent cough,...

BLU : 14.74 (unch)
BLU.TO : 19.48 (-0.10%)
3 Biotechs That Might Get Bought Out in 2023

Biotech is expected to be a hotbed of mergers and acquisitions this year.

BLU : 14.74 (unch)
RXDX : 199.92 (+0.09%)
MRK : 132.92 (-0.03%)
PFE : 27.99 (-1.30%)
GSK : 40.31 (-0.59%)
MDGL : 280.04 (-1.39%)
AMLX : 1.8500 (+1.09%)
AUPH : 5.57 (-1.59%)
Was This Acquisition a Savvy Play by This Big Pharma Stock?

The British drugmaker picked up a potential blockbuster drug in its deal for Bellus Health.

GSK : 40.31 (-0.59%)
BLU : 14.74 (unch)
MRK : 132.92 (-0.03%)
Moore Kuehn Encourages BLU, STSA, RXDX, STSA, and CHRA Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

BLU : 14.74 (unch)
STSA : 1.1000 (-0.90%)
RXDX : 199.92 (+0.09%)
Why This Nasdaq Stock Caught Fire This Week

A wave of bargain buying benefited the gene therapy company's shares this week.

BLU : 14.74 (unch)
RXDX : 199.92 (+0.09%)
TNYA : 2.86 (-7.61%)
Why Shares of Bellus Health Skyrocketed This Week

The company has received a buyout offer from GSK.

BLU : 14.74 (unch)
GSK : 40.31 (-0.59%)
MRK : 132.92 (-0.03%)
Stocks Close Slightly Higher Despite Bank Stock Weakness and Hawkish Fed Comments

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.09%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up...

$SPX : 5,469.30 (+0.39%)
SPY : 544.83 (+0.39%)
$DOWI : 39,112.16 (-0.76%)
DIA : 391.02 (-0.75%)
$IUXX : 19,701.13 (+1.16%)
QQQ : 479.38 (+1.14%)
PHM : 110.04 (-2.34%)
LEN : 149.18 (-0.98%)
DHI : 140.44 (-2.51%)
TOL : 115.68 (-2.31%)
TYL : 488.24 (-0.68%)
NVDA : 126.09 (+6.76%)
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health

GSK plc (LSE/NYSE: GSK) and BELLUS Health Inc. (TSX/NASDAQ: BLU) today announced that they have entered into an agreement under which GSK will acquire BELLUS, a Canada-based, late-stage biopharmaceutical...

BLU : 14.74 (unch)
GSK : 40.31 (-0.59%)
GSK.LN : 1,595.000 (-0.84%)
BLU.TO : 19.48 (-0.10%)
Why BELLUS Health Stock Is Rocketing Higher Today

A $2 billion buyout agreement with GSK is lighting a fire under the biotech's stock today.

RXDX : 199.92 (+0.09%)
BLU : 14.74 (unch)
GSK : 40.31 (-0.59%)
MRK : 132.92 (-0.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

BELLUS Health is a global health company focused on the development and commercialization of products to provide innovative health solutions to address critical unmet medical needs.

See More

Key Turning Points

3rd Resistance Point 14.76
2nd Resistance Point 14.75
1st Resistance Point 14.75
Last Price 14.74
1st Support Level 14.74
2nd Support Level 14.73
3rd Support Level 14.73

See More

52-Week High 14.76
Last Price 14.74
Fibonacci 61.8% 11.56
Fibonacci 50% 10.57
Fibonacci 38.2% 9.58
52-Week Low 6.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar